LOAMS
YMAB

Lombard Odier Asset Management (Switzerland)’s Y-mAbs Therapeutics YMAB Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-168,795
Closed -$2.43M – 373
2022
Q3 		$2.43M Sell
168,795
-12,138
-7% -$201K 0.21% 103
2022
Q2 		$2.74M Sell
180,933
-40,841
-18% -$476K 0.23% 97
2022
Q1 		$2.63M Sell
221,774
-163,666
-42% -$1.68M 0.21% 80
2021
Q4 		$6.25M Buy
385,440
+32,601
+9% +$697K 0.4% 61
2021
Q3 		$10.1M Buy
352,839
+32,807
+10% +$1.03M 0.63% 61
2021
Q2 		$10.8M Buy
320,032
+138,540
+76% +$4.45M 0.55% 66
2021
Q1 		$5.49M Buy
+181,492
New +$7.44M 0.36% 75

Other funds holding YMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s YMAB Position: Q4 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of Y-mAbs Therapeutics (YMAB) in Q4 2022, closing a stake of 168,795 shares — an estimated $2.43M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in YMAB in Q1 2021 and held it in 7 quarters. The position peaked at $10.8M in Q2 2021. 91 funds tracked by Wall St. Rank hold YMAB as of Q4 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Y-mAbs Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 168,795 Y-mAbs Therapeutics shares in Q4 2022, an estimated $2.43M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Y-mAbs Therapeutics in Q1 2021 and held it in 7 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Y-mAbs Therapeutics position peaked at $10.8M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 14 Feb 2023.